Cochlear
Cochlear is a leading global provider of implantable hearing solutions, known for its innovative cochlear implant systems. The company holds a strong market position due to its advanced technology and commitment to improving hearing outcomes. Cochlear's unique value lies in its continuous investment in research and development, ensuring cutting-edge solutions for hearing loss.
Short position
Cochlear (ASX:COH) has 2.14% of its shares on issue reported as short positions as of 5 Oct 2026, or about 1,400,880 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 7.65 percentage points. Its highest recorded short interest was 18.50% in July 2014. COH is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Cochlear (COH) company profile
Profile, insiders and operations
Company
AI-generated research profile of Cochlear
Operations exposure
New South WalesSome operations exposure (estimate)
Basis: Sydney HQ, R&D and manufacturing
Coarse bands are AI estimates based on public company information.
COH intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links